Theralase Technologies Inc. (TLT.V)
CAD 0.2
(0.0%)
CAD 0.2
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.37 Million CAD | 28.36% |
| 2022 | 1.06 Million CAD | 22.12% |
| 2021 | 874.79 Thousand CAD | 2.06% |
| 2020 | 857.13 Thousand CAD | -46.92% |
| 2019 | 1.61 Million CAD | -37.07% |
| 2018 | 2.56 Million CAD | 100.9% |
| 2017 | 1.27 Million CAD | 132.32% |
| 2016 | 549.74 Thousand CAD | -30.03% |
| 2015 | 785.66 Thousand CAD | 53.52% |
| 2014 | 511.75 Thousand CAD | -44.43% |
| 2013 | 920.98 Thousand CAD | -23.08% |
| 2012 | 1.19 Million CAD | 25.29% |
| 2011 | 955.71 Thousand CAD | 35.3% |
| 2010 | 706.35 Thousand CAD | 0.35% |
| 2009 | 703.9 Thousand CAD | -11.44% |
| 2008 | 794.78 Thousand CAD | 137.16% |
| 2007 | 335.12 Thousand CAD | 6.81% |
| 2006 | 313.74 Thousand CAD | 97.34% |
| 2005 | 158.98 Thousand CAD | -1.57% |
| 2004 | 161.52 Thousand CAD | -25.13% |
| 2003 | 215.74 Thousand CAD | 1912.38% |
| 2002 | 10.72 Thousand CAD | 12.16% |
| 2001 | 9559.00 CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.72 Million CAD | 35.41% |
| 2024 Q1 | 1.27 Million CAD | -6.98% |
| 2023 Q1 | 1.35 Million CAD | 26.44% |
| 2023 FY | 1.37 Million CAD | 28.36% |
| 2023 Q4 | 1.37 Million CAD | 0.23% |
| 2023 Q3 | 1.36 Million CAD | 1.89% |
| 2023 Q2 | 1.34 Million CAD | -0.58% |
| 2022 Q2 | 1.41 Million CAD | 5.87% |
| 2022 Q3 | 1.25 Million CAD | -11.05% |
| 2022 FY | 1.06 Million CAD | 22.12% |
| 2022 Q1 | 1.33 Million CAD | 52.58% |
| 2022 Q4 | 1.06 Million CAD | -15.01% |
| 2021 Q1 | 756.84 Thousand CAD | -11.7% |
| 2021 FY | 874.79 Thousand CAD | 2.06% |
| 2021 Q4 | 874.79 Thousand CAD | 6.41% |
| 2021 Q3 | 822.07 Thousand CAD | -4.62% |
| 2021 Q2 | 861.84 Thousand CAD | 13.87% |
| 2020 Q3 | 944.42 Thousand CAD | 8.93% |
| 2020 Q2 | 867 Thousand CAD | -32.22% |
| 2020 Q4 | 857.13 Thousand CAD | -9.24% |
| 2020 Q1 | 1.27 Million CAD | -20.78% |
| 2020 FY | 857.13 Thousand CAD | -46.92% |
| 2019 Q2 | 1.27 Million CAD | 31.87% |
| 2019 Q3 | 947.52 Thousand CAD | -25.89% |
| 2019 FY | 1.61 Million CAD | -37.07% |
| 2019 Q4 | 1.61 Million CAD | 70.41% |
| 2019 Q1 | 969.58 Thousand CAD | -62.21% |
| 2018 Q4 | 2.56 Million CAD | -0.95% |
| 2018 FY | 2.56 Million CAD | 100.9% |
| 2018 Q1 | 1.84 Million CAD | 44.34% |
| 2018 Q2 | 1.46 Million CAD | -20.78% |
| 2018 Q3 | 2.59 Million CAD | 77.37% |
| 2017 Q1 | 518.03 Thousand CAD | -5.77% |
| 2017 Q4 | 1.27 Million CAD | 145.42% |
| 2017 Q2 | 592.62 Thousand CAD | 14.4% |
| 2017 FY | 1.27 Million CAD | 132.32% |
| 2017 Q3 | 520.38 Thousand CAD | -12.19% |
| 2016 Q4 | 549.74 Thousand CAD | -2.39% |
| 2016 Q2 | 419.45 Thousand CAD | -40.46% |
| 2016 Q1 | 704.44 Thousand CAD | -10.34% |
| 2016 FY | 549.74 Thousand CAD | -30.03% |
| 2016 Q3 | 563.22 Thousand CAD | 34.28% |
| 2015 Q2 | 339.75 Thousand CAD | -28.35% |
| 2015 FY | 785.66 Thousand CAD | 53.52% |
| 2015 Q4 | 785.66 Thousand CAD | -4.59% |
| 2015 Q3 | 823.49 Thousand CAD | 142.38% |
| 2015 Q1 | 474.16 Thousand CAD | -7.34% |
| 2014 Q4 | 511.75 Thousand CAD | 35.77% |
| 2014 FY | 511.75 Thousand CAD | -44.43% |
| 2014 Q1 | 611.33 Thousand CAD | -33.62% |
| 2014 Q2 | 322.58 Thousand CAD | -47.23% |
| 2014 Q3 | 376.92 Thousand CAD | 16.85% |
| 2013 Q4 | 920.98 Thousand CAD | -46.2% |
| 2013 Q3 | 1.71 Million CAD | 4.03% |
| 2013 Q2 | 1.64 Million CAD | 12.36% |
| 2013 Q1 | 1.46 Million CAD | 22.3% |
| 2013 FY | 920.98 Thousand CAD | -23.08% |
| 2012 Q4 | 1.19 Million CAD | 41.04% |
| 2012 Q2 | 721.15 Thousand CAD | -31.87% |
| 2012 Q1 | 1.05 Million CAD | 10.75% |
| 2012 Q3 | 848.97 Thousand CAD | 17.72% |
| 2012 FY | 1.19 Million CAD | 25.29% |
| 2011 Q2 | 789.67 Thousand CAD | 7.58% |
| 2011 FY | 955.71 Thousand CAD | 35.3% |
| 2011 Q4 | 955.71 Thousand CAD | -14.02% |
| 2011 Q1 | 734.03 Thousand CAD | 3.92% |
| 2011 Q3 | 1.11 Million CAD | 40.77% |
| 2010 Q4 | 706.35 Thousand CAD | 3.01% |
| 2010 Q3 | 685.73 Thousand CAD | 24.56% |
| 2010 Q1 | 544.17 Thousand CAD | -22.69% |
| 2010 FY | 706.35 Thousand CAD | 0.35% |
| 2010 Q2 | 550.5 Thousand CAD | 1.16% |
| 2009 Q1 | 779.58 Thousand CAD | -1.91% |
| 2009 FY | 703.9 Thousand CAD | -11.44% |
| 2009 Q4 | 703.9 Thousand CAD | -5.44% |
| 2009 Q3 | 744.4 Thousand CAD | -10.01% |
| 2009 Q2 | 827.24 Thousand CAD | 6.11% |
| 2008 FY | 794.78 Thousand CAD | 137.16% |
| 2008 Q1 | 455.45 Thousand CAD | 35.91% |
| 2008 Q2 | 509.66 Thousand CAD | 11.9% |
| 2008 Q3 | 534.88 Thousand CAD | 4.95% |
| 2008 Q4 | 794.78 Thousand CAD | 48.59% |
| 2007 Q1 | 281.35 Thousand CAD | -10.32% |
| 2007 FY | 335.12 Thousand CAD | 6.81% |
| 2007 Q3 | 172.65 Thousand CAD | -42.0% |
| 2007 Q4 | 335.12 Thousand CAD | 94.1% |
| 2007 Q2 | 297.67 Thousand CAD | 5.8% |
| 2006 FY | 313.74 Thousand CAD | 97.34% |
| 2006 Q2 | 164.3 Thousand CAD | -37.19% |
| 2006 Q3 | 119.76 Thousand CAD | -27.11% |
| 2006 Q4 | 313.74 Thousand CAD | 161.96% |
| 2006 Q1 | 261.6 Thousand CAD | 64.54% |
| 2005 Q3 | 97.13 Thousand CAD | 8.28% |
| 2005 Q4 | 158.98 Thousand CAD | 63.67% |
| 2005 FY | 158.98 Thousand CAD | -1.57% |
| 2005 Q1 | 150.12 Thousand CAD | -7.05% |
| 2005 Q2 | 89.71 Thousand CAD | -40.24% |
| 2004 Q2 | 194.1 Thousand CAD | 0.62% |
| 2004 FY | 161.52 Thousand CAD | -25.13% |
| 2004 Q1 | 192.9 Thousand CAD | -10.59% |
| 2004 Q3 | 176.38 Thousand CAD | -9.13% |
| 2004 Q4 | 161.52 Thousand CAD | -8.43% |
| 2003 Q4 | 215.74 Thousand CAD | 947.42% |
| 2003 Q3 | 20.59 Thousand CAD | 17.53% |
| 2003 Q2 | 17.52 Thousand CAD | 2.92% |
| 2003 Q1 | 17.02 Thousand CAD | 58.83% |
| 2003 FY | 215.74 Thousand CAD | 1912.38% |
| 2002 Q2 | 18.34 Thousand CAD | 78.27% |
| 2002 Q1 | 10.28 Thousand CAD | 0.0% |
| 2002 Q4 | 10.72 Thousand CAD | 241.65% |
| 2002 Q3 | 3138.00 CAD | -82.89% |
| 2002 FY | 10.72 Thousand CAD | 12.16% |
| 2001 FY | 9559.00 CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Perimeter Medical Imaging AI, Inc. | 7.09 Million CAD | 80.672% |
| Therma Bright Inc. | 2.16 Million CAD | 36.65% |
| VentriPoint Diagnostics Ltd. | 1.69 Million CAD | 19.03% |